Compare CATX & NAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CATX | NAGE |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | United States |
| Employees | N/A | 117 |
| Industry | Medical/Dental Instruments | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 497.9M | 350.8M |
| IPO Year | 2018 | N/A |
| Metric | CATX | NAGE |
|---|---|---|
| Price | $4.24 | $4.67 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $12.11 | ★ $16.00 |
| AVG Volume (30 Days) | ★ 1.2M | 915.2K |
| Earning Date | 05-11-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $16.51 |
| Revenue Next Year | N/A | $14.58 |
| P/E Ratio | ★ N/A | $21.29 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.75 | $4.16 |
| 52 Week High | $6.16 | $14.66 |
| Indicator | CATX | NAGE |
|---|---|---|
| Relative Strength Index (RSI) | 43.31 | 50.31 |
| Support Level | $3.17 | $4.39 |
| Resistance Level | $4.64 | $5.32 |
| Average True Range (ATR) | 0.27 | 0.16 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 53.75 | 88.79 |
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
Niagen Bioscience Inc is the leader in NAD+ (nicotinamide adenine dinucleotide) science and healthy-aging research. It is dedicated to advancing healthspan through precision science and innovative NAD+-boosting solutions. It is is clinically proven to increase NAD+ levels efficiently and effectively, and is the key ingredient powering our suite of Niagen brands.